WINNIPEG, April 8 /CNW/ - IMRIS Inc. (TSX: IM) ("IMRIS" or the "Company")
participated in China's first international conference on intra-operative MR
held at PLA 301 Hospital in Beijing on April 5, 2009. Over 300 neurosurgeons
from China, USA, Germany, Taiwan and Hong Kong attended the inaugural event
that focused on developments in intra-operative MR for neurosurgery. The
conference was opened by Dir Chen Xiaohong, Director of PLA 301, and featured
scientific presentations from Peter Black, Professor of Neurosurgery, Harvard
Medical School, Christopher Nimsky, Professor and Chairman of Neurosurgery,
University Marburg, and Michael Buchfelder, Professor and Chairman of
Neurosurgery, University of Erlangen.
The conference program included the official opening of PLA 301's
IMRISneuro suite - the first-of-its-kind surgical OR with integrated
intra-operative MR imaging in China. Featuring a 1.5 Tesla wide bore magnet,
IMRISneuro provides the hospital's surgical team with high quality images
before, during and after procedures without moving the patient. Over 150 of
the conference delegates were able to observe portions of a live case tumor
resection using the new system.
PLA 301's neurosurgical team completed its first procedure on February
23, 2009, and completed five procedures in the first week of operation. In the
six weeks since installation of the IMRISneuro suite, the team treated 43
patients suffering with glioma or epilepsy. While PLA 301 is widely-recognized
for performing at the highest of global clinical standards, Dr. Xu Bainan,
Chairman of Neurosurgery, said: "IMRIS has significantly advanced our
neurosurgical capabilities and the system is contributing directly to our
hospital's reputation as a world-class facility."
At the conference, David Graves, President and CEO of IMRIS shared his
excitement about the project. "It is an honor to have been chosen by the
neurosurgical team at PLA 301", said Mr. Graves. "We are certain this
technology in their hands will help continue to provide the highest quality of
care for their patients."
IMRIS (TSX: IM) is a global leader in providing fully integrated,
advanced surgical imaging solutions. The company's flagship product,
IMRISneuro, utilizes patented technology that allows a high field MRI scanner
to be moved in to the operating room on demand, providing imaging during the
surgical procedure without compromising patient safety. This unique and
innovative system has been validated by leading neurosurgeons for use in
world-class neuroscience centers. For more information, visit www.imris.com.
For further information:
For further information: Media: Michael Robbie, Director, Marketing,
Tel: (204) 480-7696, Email: email@example.com; Investors: Brad Woods, Investor
Relations, Tel: (204) 480-7094, Email: firstname.lastname@example.org